Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?

Eur Respir J. 2018 Aug 30;52(2):1801287. doi: 10.1183/13993003.01287-2018. Print 2018 Aug.

Authors

Jana Grune¹, Wolfgang M Kuebler^{1

2

3}

Affiliations

¹ Institute of Physiology, Charité - Universitaetsmedizin, Berlin, Germany.
² The Keenan Research Centre for Biomedical Science at St. Michael's, Toronto, ON, Canada.
³ Departments of Surgery and Physiology, University of Toronto, Toronto, ON, Canada.

PMID: 30166496
DOI: 10.1183/13993003.01287-2018

No abstract available

Publication types

Editorial
Comment

MeSH terms

Endothelin Receptor Antagonists
Humans
Hypertension, Pulmonary*
Pulmonary Fibrosis*
Pyrimidines
Receptor, Endothelin A
Sulfonamides
Transforming Growth Factor beta1

Substances

Endothelin Receptor Antagonists
Pyrimidines
Receptor, Endothelin A
Sulfonamides
Transforming Growth Factor beta1
macitentan